Wird geladen...
Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris
Plaque psoriasis is a chronic debilitating condition, and biologic agents that inhibit tumor necrosis factor-α (TNF-α) are widely employed in management of the condition. Notwithstanding, several paradoxical adverse reactions have been reported with TNF-α inhibitors, including vasculitis, vitiligo,...
Gespeichert in:
| Veröffentlicht in: | Oxf Med Case Reports |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996046/ https://ncbi.nlm.nih.gov/pubmed/32038878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omz134 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|